ecancermedicalscience

Special Issue

Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis

28 Oct 2016
Rosa A van Amerongen, Valesca P Retèl, Veerle MH Coupé, Petra M Nederlof, Maartje J Vogel, Wim H van Harten

Next-generation sequencing (NGS) has reached the molecular diagnostic laboratories. Although the NGS technology aims to improve the effectiveness of therapies by selecting the most promising therapy, concerns are that NGS testing is expensive and that the ‘benefits’ are not yet in relation to these costs. In this study, we give an estimation of the costs and an institutional and national budget impact of various types of NGS tests in non-small-cell lung cancer (NSCLC) and melanoma patients within the Netherlands. First, an activity-based costing (ABC) analysis has been conducted on the costs of two examples of NGS panels (small- and medium-targeted gene panel (TGP)) based on data of the Netherlands Cancer Institute (NKI). Second, we performed a budget impact analysis (BIA) to estimate the current (2015) and future (2020) budget impact of NGS on molecular diagnostics for NSCLC and melanoma patients in the Netherlands. Literature, expert opinions, and a data set of patients within the NKI (n = 172) have been included in the BIA. Based on our analysis, we expect that the NGS cost concerns will be limited. In the current situation, NGS can indeed result in higher costs, which is mainly related to required additional tests besides the small TGP. However, in the future, we expect that the use of whole-genome sequencing (WGS) will increase, for which it is expected that additional tests can by (partly) avoided. Although the current clinical benefits are expected to be limited, the research potentials of NGS are already an important advantage.

Article metrics: 2556 views
768
1788

Related Articles

Julia Downing, Nixon Niyonzima, Sam Guma, Mwazi Batuli, Rose Kiwanuka, Innocent Atuhe, Zaitun Nalukwago, Mark Mwesiga, Warren Phipps, Henry Ddungu
Renata Colombo Bonadio, Pedro Isaacsson Velho, Guilherme Nader Marta, Mirella Nardo, Manoel Carlos LA Souza, David QB Muniz, Regis OF Bezerra, Raisa KA Bispo, Sheila F Faraj, Diogo A Bastos, Carlos Dzik
Belinda F Morrison, William D Aiken, Gareth Reid, Richard Mayhew, Barrie Hanchard